Assyro AI

Orange Book product · Brand (NDA)

SEGLUROMET

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand (NDA)NDA 209806RX MSD SUB MERCK

At a glance

Dec 19, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 19, 2017

    8 yr 7 mo ago

  2. Today

  3. Patent 9308204 expires

    Listed drug product patent expiration.

    Oct 21, 2030

    in 4 yr 5 mo

  4. Patent 9439902 expires

    Listed method-of-use patent (U-2214) expiration.

    Oct 21, 2030

    in 4 yr 5 mo

  5. Patent 8080580 expires

    Listed drug substance patent expiration.

    Dec 19, 2031

    in 5 yr 7 mo

Pharmaceutical detail

Active ingredient

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Strength

2.5MG;1GM

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 209806

Product number

002

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9308204Oct 21, 2030in 4 yr 5 mo
Product
9439902Oct 21, 2030in 4 yr 5 mo
U-2214
8080580Dec 19, 2031in 5 yr 7 mo
SubstanceProductU-2214
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.